Work

P1.11.35 RATIONALE-303: Long-Term Outcomes With Tislelizumab in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer

Year: 2025

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.335

Authors: C. Zhou, Y. Fan, Z. Ma, Y. Cheng, Y. Wang, Y.Y. Bao, W. Zheng, K. Naicker, P.R.M. de Marchi

Institutions: Tongji University, Shanghai East Hospital, Zhejiang Cancer Hospital, University of Chinese Academy of Sciences, Zhengzhou University, Henan Cancer Hospital, Jilin Province Tumor Hospital, BeOne Medicines (Switzerland)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415519348

FWCI:

Cites:

Cited by:

Related to: 10